JCRB1050 OVMIU-II
Cell information
Important Notice(s)Problem of JCRB1047 OVSAYO、JCRB1049 OVMIU、JCRB1050 OVMIU-II
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1050 | Cell Name | OVMIU-II |
---|---|---|---|
Profile | Human cell line derived from ovarian tumour. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | 46 |
Identity | available | Tissue for Primary Cancer | ovary |
Case history | ovarian carcinoma, stage IIIc, CBDCA + TXL(4) treatment done before. | Metastasis | No |
Tissue Metastasized | recurrent tumor | Genetics | tumour markers, CA125, ALP. |
Life Span | infinite | Crisis PDL | |
Morphology | epithelial-like | Character | Experiments on mouse transplantation have not been done. |
Classify | tumour | Established by | Gorai,I. et.al. |
Registered by | Gorai,I. | Regulation for Distribution | |
Comment | The STR pattern was unique while the pattern is expected to be same with the OVMIU. | Year | 2002 |
Medium | RPMI1640 medium with 10% fetal bovine serum. | Methods for Passages | Cells are harvested after treatment with 0.05% trypsin. Change medium every 3-4 days. |
Cell Number on Passage | 5 x 10^4 cells/ml | Race | Japanese |
CO2 Conc. | 5 % | Tissue Sampling | reccurrent forcus |
Tissue Type | adeno carcinoma |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:11121861 | Cyclophosphamide and 5-fluorouracil act synergistically in ovarian clear cell adenocarcinoma cells. Ohta I,Gorai I,Miyamoto Y,Yang J,Zheng JH,Kawata N,Hirahara F,Shirotake S Cancer Lett. 2001 Jan 10;162(1):39-48 |
Pubmed id:9328139 | Complexity of expression of the intermediate filaments of six new human ovarian carcinoma cell lines: new expression of cytokeratin 20. Yanagibashi T,Gorai I,Nakazawa T,Miyagi E,Hirahara F,Kitamura H,Minaguchi H Br J Cancer. 1997;76(7):829-35 |
Pubmed id:7535723 | Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties. Gorai I,Nakazawa T,Miyagi E,Hirahara F,Nagashima Y,Minaguchi H Gynecol Oncol. 1995 Apr;57(1):33-46 |
Pubmed id:7882618 | Marked induction of gelatinases, especially type B, in host fibroblasts by human ovarian cancer cells in athymic mice. Miyagi E,Yasumitsu H,Hirahara F,Nagashima Y,Minaguchi H,Miyazaki K,Umeda M Clin Exp Metastasis. 1995 Mar;13(2):89-96 |
Images |
---|
PDF File1 PDF File2 |
LOT Information
Cell No. | JCRB1050 | Cell Name | OVMIU-II |
---|---|---|---|
LOT No. | 08092010 | Lot Specification | distribution |
Medium | RPMI1640 medium with 15% heat inactivated fetal bovine serum(SIGMA027K03911) | Temperature | 37 C |
Cell Density at Seeding | 0.55-1.8x10^4 cells/sq.cm | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.55x10^6 |
Viability at cell freezing (%) | 96.9 | Antibiotics Used | free |
Passage Number | p47 | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:13 D13S317:14 D7S820:13,14 D16S539:11 VWA:14 TH01:9 AM:X TPOX:9,11 CSF1PO:12 |
Adhesion | Yes | Exoteric Gene | NT |
Medium for Freezing | Cell Banker BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|
Cell No. | JCRB1050 | Cell Name | OVMIU-II |
---|---|---|---|
LOT No. | 05012003 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal calf serum (Intergen RB52305). | Temperature | 37 C |
Cell Density at Seeding | 1.0 x 10^4 cells/sq.cm. | Methods for Passages | Cells are harvested after treatment with 0.05% trypsin. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.3 x 10^6 |
Viability at cell freezing (%) | 98.9 | Antibiotics Used | free |
Passage Number | P43 | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | G6PD(typeB), NP, LDH. Human, not HeLa. |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | |
Adhesion | Yes | Exoteric Gene | NT |
Medium for Freezing | Culture medium with 5% DMSO. | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|